Atopic Dermatitis Drugs Market - Global Industry Analysis

The global atopic dermatitis drugs market was estimated at 4.1 (USD Billion) in 2019 and is projected to hit the revenue of 5.09 (USD Billion) by 2025 at a CAGR of around 4.34% over the period from 2019 to 2025. The report offers valuation and analysis of the atopic dermatitis drugs market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, limitations, sales estimates, avenues, current & emerging trends, and industry-validated market data. The report offers historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on value (USD Billion).

Details of the Report:

Introduction

Atopic dermatitis is common, serious, and inflammatory skin disorders that largely affect the child population. The inflammatory skin conditions include psoriasis, tinea, erythroderma, and dermatitis. According to NCBI, atopic dermatitis affects nearly twenty percent of children and ten percent of adults in developed nations.  For the record, atopic dermatitis affects nearly 13% of children and 10% of adults in the U.S. Furthermore, the patients and their families have felt a large impact on the quality of life as a well fiscal burden.

The clinical characteristics of atopic dermatitis include excoriations, crusting, erythema, oozing, lichenification, and edema. Additionally, pruritus is the major property of atopic dermatitis and produces comorbidities like mental distress and sleep loss, thereby creating a huge affliction to parents as well as patients. Reportedly, genetic aspects and ecological factors strongly impact atopic dermatitis.

Additionally, there is a large occurrence of the disorder in emerging nations. The disease exemplifies massive heterogeneity in the medical severity, disease phenotype, persistence, response to the treatment, and persistence. The key goals of treating the disease through drugs are to reduce inflammation of the skin as well as pruritus and flare prevention.

Market Growth Dynamics

New concepts in disease pathogenesis have prompted research & development activities for creating novel medicines to treat disease.  Additionally, a large spectrum of medicines is utilized for treating skin disease and they include steroids, moisturizing creams, and calcineurin inhibitors. All these beneficial aspects are anticipated to drive the growth of the atopic dermatitis drugs market over the forecast timeline.

Apart from this, the introduction of biologic medicines has helped treat atopic dermatitis. Additionally, new biologic drugs including dupilumab and crisaborole are also used for treating atopic dermatitis. Reportedly, the former drug was first approved for treating atopic dermatitis in adults across the regions such as Japan, North America, and Europe.

For the record, dupilumab is the only biologic medicine approved by the European Medicines Agency and the U.S. Food and Drug Administration for treating adult subjects. Moreover, biologic medicines can treat adult patients as these drugs provide convenient dose schedules and assist in effective lab monitoring as compared to other forms of systemic treatments along with reduced side effects. All these factors are anticipated to bring a paradigm shift in the atopic dermatitis drugs industry over the forthcoming years.

North American Market To Acquire Numero Uno Position By 2025

The growth of the regional market over the forecast period is subject to surge in the incidences of atopic dermatitis in children along with rising in the frequency of skin allergies in adult population in the countries like the U.S. Apparently, launching of new drugs in the foreseeable future will further enlarge the business scope over the ensuing years.

Key players included in the atopic dermatitis drugs market are:

• Meda Pharmaceuticals
• Bayer AG
• Encore Dermatology
• Leo Pharma
• Valent Pharmaceutical Inc.

The global atopic dermatitis drugs market is segmented as follows:

By Therapy

• Photo Therapy
• Directed Therapy

By Route of Administration

• Injectable
• Clinics
• Research Labs

By End User

• Injectable
• Clinics
• Research Labs

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

• Chapter 1. Preface
  • 1.1. Report Description and Scope
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology
• Chapter 2. Executive Summary
  • 2.1. Atopic Dermatitis Drugs Market, 2016–2025 (USD Billion)
  • 2.2. Atopic Dermatitis Drugs Market: Snapshot
• Chapter 3. Global Atopic Dermatitis Drugs Market– Industry Analysis
  • 3.1. Atopic Dermatitis Drugs Market: Market Dynamics
  • 3.2. Market Drivers
    • 3.2.1. Launching of biulogic drugs to boost the product demand
    • 3.2.2. Approval of the product for treating atopic dermatitis in Europe, North America, and Japan will boost the market performance
  • 3.3. Porter’s Five Forces Analysis
  • 3.4. Market Attractiveness Analysis
    • 3.4.1. Market attractiveness analysis By Therapy
    • 3.4.2. Market attractiveness analysis By Route of Administration
    • 3.4.3. Market attractiveness analysis By End User
    • 3.4.4. Market attractiveness analysis by Region
• Chapter 4. Global Atopic Dermatitis Drugs Market– Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global Atopic Dermatitis Drugs Market: company market share, 2018
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New Product launches
    • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
    • 4.2.4. Research and development and Regional expansion
  • 4.3. Price trend analysis
• Chapter 5. Global Atopic Dermatitis Drugs Market–Therapy Analysis
  • 5.1. Global Atopic Dermatitis Drugs Market overview: By Therapy
    • 5.1.1. Global Atopic Dermatitis Drugs Market share, By Therapy,2018 and 2025
  • 5.2. Photo Therapy
    • 5.2.1. Global Atopic Dermatitis Drugs Market by Photo Therapy, 2016–2025 (USD Billion)
  • 5.3. Directed Therapy
    • 5.3.1. Global Atopic Dermatitis Drugs Market by Directed Therapy, 2016–2025 (USD Billion)
• Chapter 6. Global Atopic Dermatitis Drugs Market– Route of Administration Analysis
  • 6.1. Global Atopic Dermatitis Drugs Market overview: By Route of Administration
    • 6.1.1. Global Atopic Dermatitis Drugs Market share, By Route of Administration, 2018 and 2025
  • 6.2. Injectable
    • 6.2.1. Global Atopic Dermatitis Drugs Market By Injectable, 2016–2025 (USD Billion)
  • 6.3. Clinics
    • 6.3.1. Global Atopic Dermatitis Drugs Market By Clinics, 2016–2025 (USD Billion)
  • 6.4. Research Labs
    • 6.4.1. Global Atopic Dermatitis Drugs Market By Research Labs, 2016–2025 (USD Billion)
• Chapter 7. Global Atopic Dermatitis Drugs Market– End User Analysis
  • 7.1. Global Atopic Dermatitis Drugs Market overview: By End User
    • 7.1.1. Global Atopic Dermatitis Drugs Market share, By End User, 2018 and 2025
  • 7.2. Hospitals
    • 7.2.1. Global Atopic Dermatitis Drugs Market By Hospitals, 2016–2025 (USD Billion)
  • 7.3. Clinics
    • 7.3.1. Global Atopic Dermatitis Drugs Market By Clinics, 2016–2025 (USD Billion)
  • 7.4. Research Labs
    • 7.4.1. Global Atopic Dermatitis Drugs Market By Research Labs, 2016–2025 (USD Billion)
• Chapter 8. Company Profiles
  • 8.1. Meda Pharmaceuticals
    • 8.1.1. Overview
    • 8.1.2. Financials
    • 8.1.3. Product Portfolio
    • 8.1.4. Business Strategy
    • 8.1.5. Recent Developments
  • 8.2. Leo Pharma
    • 8.2.1. Overview
    • 8.2.2. Financials
    • 8.2.3. Product Portfolio
    • 8.2.4. Business Strategy
    • 8.2.5. Recent Developments
  • 8.3. Bayer AG
    • 8.3.1. Overview
    • 8.3.2. Financials
    • 8.3.3. Product Portfolio
    • 8.3.4. Business Strategy
    • 8.3.5. Recent Developments
  • 8.4. Valent Pharmaceutical Inc.
    • 8.4.1. Overview
    • 8.4.2. Financials
    • 8.4.3. Product Portfolio
    • 8.4.4. Business Strategy
    • 8.4.5. Recent Developments
  • 8.5. Encore Dermatulogy
    • 8.5.1. Overview
    • 8.5.2. Financials
    • 8.5.3. Product Portfolio
    • 8.5.4. Business Strategy
    • 8.5.5. Recent Development

List of Figures

1. Market research process
2. Market research methodology
3. Global Atopic Dermatitis Drugs Market, 2016–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Atopic Dermatitis Drugs Market attractiveness, By Therapy
6. Global Atopic Dermatitis Drugs Market attractiveness, By Route of Administration
7. Global Atopic Dermatitis Drugs Market attractiveness, By End User
8. Global Atopic Dermatitis Drugs Market attractiveness, By Therapy
9. Global Atopic Dermatitis Drugs Market share, By Therapy, 2018 and 2025
10. Global Atopic Dermatitis Drugs Market by Photo Therapy, 2016–2025 (USD Billion)
11. Global Atopic Dermatitis Drugs Market by Directed Therapy,2016–2025 (USD Billion)
12. Global Atopic Dermatitis Drugs Market Share by Route of Administration,2018 and 2025 (USD Billion)
13. Global Atopic Dermatitis Drugs Market by Injectable,2016–2025 (USD Billion)
14. Global Atopic Dermatitis Drugs Market by Oral,2016–2025 (USD Billion)
15. Global Atopic Dermatitis Drugs Market by Topical,2016–2025 (USD Billion)
16. Global Atopic Dermatitis Drugs Market Share by End User,2018 and 2025 (USD Billion)
17. Global Atopic Dermatitis Drugs Market by Hospitals,2016–2025 (USD Billion)
18. Global Atopic Dermatitis Drugs Market by Clinics,2016–2025 (USD Billion)
19. Global Atopic Dermatitis Drugs Market by Research Labs,2016–2025 (USD Billion)
20. Global Atopic Dermatitis Drugs Market share, by Region, 2018 and 2025
21. North America Atopic Dermatitis Drugs Market, 2016–2025 (USD Billion)
22. Europe Atopic Dermatitis Drugs Market, 2016–2025 (USD Billion)
23. Asia Pacific Atopic Dermatitis Drugs Market, 2016–2025 (USD Billion)
24. Latin America Atopic Dermatitis Drugs Market, 2016–2025 (USD Billion)
25. The Middle East and Africa Atopic Dermatitis Drugs Market, 2016–2025 (USD Billion)

List of Tables

1. Global Atopic Dermatitis Drugs Market: snapshot
2. Drivers of the Atopic Dermatitis Drugs Market: impact analysis
3. North America Atopic Dermatitis Drugs Market revenue, By Therapy ,2016–2025 (USD Billion)
4. North America Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2016–2025 (USD Billion)
5. North America Atopic Dermatitis Drugs Market Revenue, By End User, 2016–2025 (USD Billion)
6. The U.S. Atopic Dermatitis Drugs Market revenue, By Therapy, 2016–2025 (USD Billion)
7. The U.S. Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2016–2025 (USD Billion)
8. The U.S. Atopic Dermatitis Drugs Market Revenue, By End User, 2016–2025 (USD Billion)
9. Rest of North America Atopic Dermatitis Drugs Market revenue, By Therapy ,2016–2025 (USD Billion)
10. Rest of North America Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2016–2025 (USD Billion)
11. Rest of North America Atopic Dermatitis Drugs Market Revenue, By End User, 2016–2025 (USD Billion)
12. Europe Atopic Dermatitis Drugs Market revenue, By Therapy, 2016–2025 (USD Billion)
13. Europe Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2016–2025 (USD Billion)
14. Europe Atopic Dermatitis Drugs Market Revenue, By End User, 2016–2025 (USD Billion)
15. UK Atopic Dermatitis Drugs Market revenue, By Therapy  ,2016–2025 (USD Billion)
16. UK Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2016–2025 (USD Billion)
17. UK Atopic Dermatitis Drugs Market Revenue, By End User, 2016–2025 (USD Billion)
18. France Atopic Dermatitis Drugs Market revenue, By Therapy ,2016–2025 (USD Billion)
19. France Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2016–2025 (USD Billion)
20. France Atopic Dermatitis Drugs Market Revenue, By End User, 2016–2025 (USD Billion)
21. Germany Atopic Dermatitis Drugs Market revenue, By Therapy ,2016–2025 (USD Billion)
22. Germany Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2016–2025 (USD Billion)
23. Germany Atopic Dermatitis Drugs Market Revenue, By End User, 2016–2025 (USD Billion)
24. Rest of Europe Atopic Dermatitis Drugs Market revenue, By Therapy,2016–2025 (USD Billion)
25. Rest of Europe Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2016–2025 (USD Billion)
26. Rest of Europe Atopic Dermatitis Drugs Market Revenue, By End User, 2016–2025 (USD Billion)
27. Asia Pacific Atopic Dermatitis Drugs Market revenue, By Therapy ,2016–2025 (USD Billion)
28. Asia Pacific Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2016–2025 (USD Billion)
29. Asia Pacific Atopic Dermatitis Drugs Market Revenue, By End User, 2016–2025 (USD Billion)
30. China Atopic Dermatitis Drugs Market revenue, By Therapy ,2016–2025 (USD Billion)
31. China Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2016–2025 (USD Billion)
32. China Atopic Dermatitis Drugs Market Revenue, By End User, 2016–2025 (USD Billion)
33. Japan Atopic Dermatitis Drugs Market revenue, By Therapy, 2016–2025 (USD Billion)
34. Japan Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2016–2025 (USD Billion)
35. Japan Atopic Dermatitis Drugs Market Revenue, By End User, 2016–2025 (USD Billion)
36. India Atopic Dermatitis Drugs Market revenue, By Therapy ,2016–2025 (USD Billion)
37. India Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2016–2025 (USD Billion)
38. India Atopic Dermatitis Drugs Market Revenue, By End User, 2016–2025 (USD Billion)
39. Rest of Asia Pacific Atopic Dermatitis Drugs Market revenue, By Therapy ,2016–2025 (USD Billion)
40. Rest of Asia Pacific Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2016–2025 (USD Billion)
41. Rest of Asia Pacific Atopic Dermatitis Drugs Market Revenue, By End User, 2016–2025 (USD Billion)
42. Latin America Atopic Dermatitis Drugs Market revenue, By Therapy ,2016–2025 (USD Billion)
43. Latin America Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2016–2025 (USD Billion)
44. Latin America Atopic Dermatitis Drugs Market Revenue, By End User, 2016–2025 (USD Billion)
45. Brazil Atopic Dermatitis Drugs Market revenue, By Therapy ,2016–2025 (USD Billion)
46. Brazil Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2016–2025 (USD Billion)
47. Brazil Atopic Dermatitis Drugs Market Revenue, By End User, 2016–2025 (USD Billion)
48. Rest of Latin America Atopic Dermatitis Drugs Market revenue, By Therapy ,2016–2025 (USD Billion)
49. Rest of Latin America Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2016–2025 (USD Billion)
50. Rest of Latin America Atopic Dermatitis Drugs Market Revenue, By End User, 2016–2025 (USD Billion)
51. The Middle East and Africa Atopic Dermatitis Drugs Market revenue, By Therapy ,2016–2025 (USD Billion)
52. The Middle East and Africa Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2016–2025 (USD Billion)
53. The Middle East and Africa Atopic Dermatitis Drugs Market Revenue, By End User, 2016–2025 (USD Billion)
54. Saudi Arabia Atopic Dermatitis Drugs Market revenue, By Therapy, 2016–2025 (USD Billion)
55. Saudi Arabia Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2016–2025 (USD Billion)
56. Saudi Arabia Atopic Dermatitis Drugs Market Revenue, By End User, 2016–2025 (USD Billion)
57. South Africa Atopic Dermatitis Drugs Market revenue, By Therapy ,2016–2025 (USD Billion)
58. South Africa Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2016–2025 (USD Billion)
59. South Africa Atopic Dermatitis Drugs Market Revenue, By End User, 2016–2025 (USD Billion)
60. Rest of the Middle East & Africa Atopic Dermatitis Drugs Market revenue, By Therapy ,2016–2025 (USD Billion)
61. Rest of the Middle East & Africa Atopic Dermatitis Drugs Market revenue, By Route of Administration, 2016–2025 (USD Billion)
62. Rest of the Middle East & Africa Atopic Dermatitis Drugs Market Revenue, By End User, 2016–2025 (USD Billion)